These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38867349)

  • 1. Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
    Stieglitz E; Lee AG; Angus SP; Davis C; Barkauskas DA; Hall D; Kogan SC; Meyer J; Rhodes SD; Tasian SK; Xuei X; Shannon K; Loh ML; Fox E; Weigel BJ
    Cancer Discov; 2024 Sep; 14(9):1590-1598. PubMed ID: 38867349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. If You Build It, Patients with Rare Cancers Will Come: A Successful Clinical Trial in Relapsed and Refractory JMML.
    Ben-Crentsil NA; Padron E
    Cancer Discov; 2024 Sep; 14(9):1574-1576. PubMed ID: 39228296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model.
    Lee AQ; Konishi H; Ijiri M; Li Y; Panigrahi A; Chien J; Satake N
    Pediatr Hematol Oncol; 2024 Aug; 41(5):367-375. PubMed ID: 38647418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
    Stieglitz E; Ward AF; Gerbing RB; Alonzo TA; Arceci RJ; Liu YL; Emanuel PD; Widemann BC; Cheng JW; Jayaprakash N; Balis FM; Castleberry RP; Bunin NJ; Loh ML; Cooper TM
    Pediatr Blood Cancer; 2015 Apr; 62(4):629-36. PubMed ID: 25704135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
    Perreault S; Larouche V; Tabori U; Hawkin C; Lippé S; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; Sultan S; Cantin É; Routhier MÈ; Caru M; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Jabado N
    BMC Cancer; 2019 Dec; 19(1):1250. PubMed ID: 31881853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.
    Borthakur G; Popplewell L; Boyiadzis M; Foran J; Platzbecker U; Vey N; Walter RB; Olin R; Raza A; Giagounidis A; Al-Kali A; Jabbour E; Kadia T; Garcia-Manero G; Bauman JW; Wu Y; Liu Y; Schramek D; Cox DS; Wissel P; Kantarjian H
    Cancer; 2016 Jun; 122(12):1871-9. PubMed ID: 26990290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
    Niemeyer CM; Flotho C; Lipka DB; Starý J; Rössig C; Baruchel A; Klingebiel T; Micalizzi C; Michel G; Nysom K; Rives S; Schmugge Liner M; Zecca M; Schönung M; Baumann I; Nöllke P; Benettaib B; Biserna N; Poon J; Simcock M; Patturajan M; Menezes D; Gaudy A; van den Heuvel-Eibrink MM; Locatelli F
    Blood Adv; 2021 Jul; 5(14):2901-2908. PubMed ID: 34297046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.
    Patel SA; Coulter DW; Grovas AC; Gordon BG; Harper JL; Warkentin PI; Wisecarver JL; Sanger WG; Coccia PF
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):491-4. PubMed ID: 24322499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling.
    Coggins GE; Farrel A; Rathi KS; Hayes CM; Scolaro L; Rokita JL; Maris JM
    Cancer Res; 2019 Dec; 79(24):6204-6214. PubMed ID: 31672841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia.
    Pasupuleti SK; Chao K; Ramdas B; Kanumuri R; Palam LR; Liu S; Wan J; Annesley C; Loh ML; Stieglitz E; Burke MJ; Kapur R
    Mol Ther; 2023 Apr; 31(4):986-1001. PubMed ID: 36739480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic characteristics and survival analysis of 27 cases of juvenile myelomonocytic leukemia].
    Li JJ; Hu T; Li JH; Zhang ZX; Feng SQ; Shi XD; Zhang L; Cao J; Song ZL; Hu MZ; Zhong DX; Yue M; Fan W; Tang RH; Zou BH; Liu R
    Zhonghua Er Ke Za Zhi; 2023 Jan; 61(1):56-60. PubMed ID: 36594122
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.
    Blumenschein GR; Smit EF; Planchard D; Kim DW; Cadranel J; De Pas T; Dunphy F; Udud K; Ahn MJ; Hanna NH; Kim JH; Mazieres J; Kim SW; Baas P; Rappold E; Redhu S; Puski A; Wu FS; Jänne PA
    Ann Oncol; 2015 May; 26(5):894-901. PubMed ID: 25722381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azacitidine (Vidaza
    Rubio-San-Simón A; van Eijkelenburg NKA; Hoogendijk R; Hasle H; Niemeyer CM; Dworzak MN; Zecca M; Lopez-Yurda M; Janssen JM; Huitema ADR; van den Heuvel-Eibrink MM; Laille EJ; van Tinteren H; Zwaan CM
    Paediatr Drugs; 2023 Nov; 25(6):719-728. PubMed ID: 37695474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single-center retrospective study from China.
    Lin YC; Luo CJ; Miao Y; Wang JM; Luo CY; Qin X; Cai JY; Li BS; Chen J
    Pediatr Transplant; 2021 Mar; 25(2):e13825. PubMed ID: 33131184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells.
    Tasian SK; Casas JA; Posocco D; Gandre-Babbe S; Gagne AL; Liang G; Loh ML; Weiss MJ; French DL; Chou ST
    Leukemia; 2019 Jan; 33(1):181-190. PubMed ID: 29884903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study.
    Peng Z; Gao J; Huang L; He Y; Tang H; Zong S; Pei Y; Pei F; Ge J; Liu X; Yue L; Zhou J; Li X; Yue D; Chen Y; Chen C; Wu X; Feng X; Li C
    Front Immunol; 2024; 15():1426640. PubMed ID: 39253078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Gene Mutation and Clinical Characteristics in 19 Children with Juvenile Myelomonocytic Leukemia].
    Weng KZ; Zheng YZ; Zhuang SQ; Chen HY; LE SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1811-1818. PubMed ID: 33283703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.
    Locatelli F; Nöllke P; Zecca M; Korthof E; Lanino E; Peters C; Pession A; Kabisch H; Uderzo C; Bonfim CS; Bader P; Dilloo D; Stary J; Fischer A; Révész T; Führer M; Hasle H; Trebo M; van den Heuvel-Eibrink MM; Fenu S; Strahm B; Giorgiani G; Bonora MR; Duffner U; Niemeyer CM; ;
    Blood; 2005 Jan; 105(1):410-9. PubMed ID: 15353481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer.
    Wu C; Williams TM; Robb R; Webb A; Wei L; Chen W; Mikhail S; Ciombor KK; Cardin DB; Timmers C; Krishna SG; Arnold M; Harzman A; Abdel-Misih S; Roychowdhury S; Bekaii-Saab T; Wuthrick E
    Clin Cancer Res; 2020 Jul; 26(13):3117-3125. PubMed ID: 32253228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.